Evidence map›Paper›PMID 35437827›Full record

ArticleHistopathology2022

CA9 expression in breast implant-associated anaplastic large cell lymphoma presenting in a lymph node.

Naoki Oishi, Andrew L Feldman

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Histopathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Naoki OishiDepartment of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan.ORCID 0000-0002-9365-1093
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-5009-4808
Mayo Clinic · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Preclinical Models and Therapeutics CoreP01CA229100 · NCI · MAYO CLINIC ARIZONA · PI INGHIRAMI, GIORGIO · 2018 to 2022
$10.2M
NCATS NIH HHS UL1 TR002377NCI NIH HHS P01 CA229100
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast ImplantsBreast NeoplasmsLymphoma, Large-Cell, AnaplasticAntigens, NeoplasmCarbonic Anhydrase IXFemaleHumansLymph NodesAntigens, NeoplasmCA9 protein, humanCarbonic Anhydrase IXanaplastic large cell lymphomabreast implantcarbonic anhydrase

Identifiers

PMID35437827
PMCPMC9308674
OpenAlexW4224271782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.